• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症进展的巴别塔中的TP53突变体

TP53 mutants in the tower of babel of cancer progression.

作者信息

Bisio Alessandra, Ciribilli Yari, Fronza Gilberto, Inga Alberto, Monti Paola

机构信息

Laboratory of Transcriptional Networks, Centre for Integrative Biology (CIBIO), University of Trento, Trento, Italy.

出版信息

Hum Mutat. 2014 Jun;35(6):689-701. doi: 10.1002/humu.22514. Epub 2014 Mar 14.

DOI:10.1002/humu.22514
PMID:24449472
Abstract

Loss-of-function, partial-function, altered-function, dominant-negative, temperature sensitive, interfering, contact, structural, unfolded, misfolded, dimeric, monomeric, non-cooperative, unstable, supertrans, superstable, intragenic suppressor. TP53 mutants are many, more than 2,000 in fact, and they can be very diverse. Sporadic; germline; gain-of-function (GoF); oncogenic; rebel-angel; yin and yang; prion-like; metastasis-inducer; mediator of chemo-resistance; modifier of stemness. TP53 mutants can impact important cancer clinical variables, in multiple, often subtle ways, as revealed by cell-based assays as well as animal models. Here, we review studies investigating TP53 mutants for their effect on sequence-specific transactivation function, and especially recent findings on how TP53 mutants can exhibit GoF properties. We also review reports on TP53 mutants' impact on cancer cell transcriptomes and studies with Li-Fraumeni patients trying to classify and predict phenotypes in relation to experimentally determined transcription fingerprints. Finally, we provide an example of the complexity of correlating TP53 mutant functionality to clinical variables in sporadic cancer patients. Conflicting results and limitations of experimental approaches notwithstanding, the study of TP53 mutants has provided a rich body of knowledge, mostly available in the public domain and accessible through databases, which is beginning to impact cancer intervention strategies.

摘要

功能丧失、部分功能、功能改变、显性负性、温度敏感、干扰性、接触性、结构性、未折叠、错误折叠、二聚体、单体、非协同性、不稳定、超转录、超稳定、基因内抑制子。TP53突变体众多,实际上超过2000种,而且它们可能非常多样。散发性;种系性;功能获得(GoF);致癌性;叛逆天使;阴阳;朊病毒样;转移诱导剂;化疗抗性介质;干性调节因子。如基于细胞的检测以及动物模型所揭示的,TP53突变体可以通过多种往往很微妙的方式影响重要的癌症临床变量。在此,我们综述了研究TP53突变体对序列特异性反式激活功能影响的研究,尤其是关于TP53突变体如何表现出功能获得特性的最新发现。我们还综述了关于TP53突变体对癌细胞转录组影响的报告以及对李-弗劳梅尼患者的研究,这些研究试图根据实验确定的转录指纹对表型进行分类和预测。最后,我们提供了一个将TP53突变体功能与散发性癌症患者临床变量相关联的复杂性的例子。尽管存在相互矛盾的结果和实验方法的局限性,但对TP53突变体的研究已经提供了丰富的知识体系,大多可在公共领域获取并可通过数据库访问,这正开始影响癌症干预策略。

相似文献

1
TP53 mutants in the tower of babel of cancer progression.癌症进展的巴别塔中的TP53突变体
Hum Mutat. 2014 Jun;35(6):689-701. doi: 10.1002/humu.22514. Epub 2014 Mar 14.
2
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.180 个疑似李-佛美尼综合征家族的 TP53 种系突变检测:不同家族表型中癌症的突变检出率和相对频率。
J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.
3
Germline TP53 mutations and Li-Fraumeni syndrome.种系TP53突变与李-弗劳梅尼综合征。
Hum Mutat. 2003 Mar;21(3):313-20. doi: 10.1002/humu.10185.
4
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.在李-佛美尼综合征家族中,癌症表型与先天性TP53基因型相关。
Oncogene. 1998 Sep 3;17(9):1061-8. doi: 10.1038/sj.onc.1202033.
5
Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.巴西南部儿童癌症患者中李-佛美尼综合征和李-佛美尼样综合征。
Cancer. 2013 Dec 15;119(24):4341-9. doi: 10.1002/cncr.28346. Epub 2013 Oct 7.
6
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.李-弗劳梅尼综合征及相关综合征:肿瘤类型、家族结构与TP53基因分型之间的相关性
Cancer Res. 2003 Oct 15;63(20):6643-50.
7
Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome.肿瘤蛋白 53 突变与遗传性癌症:超越李-佛美尼综合征。
Curr Opin Oncol. 2010 Jan;22(1):64-9. doi: 10.1097/CCO.0b013e328333bf00.
8
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.TP53基因的R337H突变与巴西家族中的李-佛美尼综合征及李-佛美尼样综合征相关。
Cancer Lett. 2007 Jan 8;245(1-2):96-102. doi: 10.1016/j.canlet.2005.12.039. Epub 2006 Feb 21.
9
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.人类癌症中的TP53突变:功能选择及其对癌症预后和结局的影响。
Oncogene. 2007 Apr 2;26(15):2157-65. doi: 10.1038/sj.onc.1210302.
10
Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome.在一位具有李-佛美尼综合征样特征的患者中鉴定到的新型种系 p53 剪接突变的功能研究。
Mol Carcinog. 2013 Oct;52(10):770-6. doi: 10.1002/mc.21912. Epub 2012 Apr 11.

引用本文的文献

1
Concomitant and Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis.乳腺癌中的伴随性和突变:临床病理与突变特征、新辅助治疗反应及预后分析
J Breast Cancer. 2023 Aug;26(4):363-377. doi: 10.4048/jbc.2023.26.e30. Epub 2023 Jul 12.
2
Unaffected Li-Fraumeni Syndrome Carrier Parent Demonstrates Allele-Specific mRNA Stabilization of Wild-Type Compared to Affected Offspring.未受影响的 Li-Fraumeni 综合征携带者父母与受影响的后代相比,表现出野生型等位基因特异性 mRNA 稳定。
Genes (Basel). 2022 Dec 7;13(12):2302. doi: 10.3390/genes13122302.
3
Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification.
乳腺癌中同时存在 TP53 突变和 MYC 扩增的独特临床病理特征、基因组改变和预后。
Thorac Cancer. 2022 Dec;13(24):3441-3450. doi: 10.1111/1759-7714.14703. Epub 2022 Oct 28.
4
Mutant p53 expression enables a partial capacity to modulate metabolism.突变型p53的表达使细胞具备部分调节代谢的能力。
Front Genet. 2022 Sep 26;13:974662. doi: 10.3389/fgene.2022.974662. eCollection 2022.
5
Targeting Post-Translational Regulation of p53 in Colorectal Cancer by Exploiting Vulnerabilities in the p53-MDM2 Axis.通过利用p53-MDM2轴中的脆弱性靶向结直肠癌中p53的翻译后调控
Cancers (Basel). 2022 Jan 3;14(1):219. doi: 10.3390/cancers14010219.
6
Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings.病例报告:两兄妹均患李-佛美尼综合征合并中枢神经系统肿瘤。
BMC Pediatr. 2021 Dec 27;21(1):588. doi: 10.1186/s12887-021-03070-8.
7
One-Two Punch Therapy for the Treatment of T-Cell Malignancies Involving p53-Dependent Cellular Senescence.针对涉及 p53 依赖性细胞衰老的 T 细胞恶性肿瘤的双管齐下疗法。
Oxid Med Cell Longev. 2021 Sep 21;2021:5529518. doi: 10.1155/2021/5529518. eCollection 2021.
8
Heterogeneity of Mutations and P53 Protein Residual Function in Cancer: Does It Matter?癌症中突变的异质性与P53蛋白残余功能:这重要吗?
Front Oncol. 2020 Oct 28;10:593383. doi: 10.3389/fonc.2020.593383. eCollection 2020.
9
Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients.慢性淋巴细胞白血病中首次治疗时间和 P53 功能障碍:早期患者 O-CLL1 研究结果。
Sci Rep. 2020 Oct 28;10(1):18427. doi: 10.1038/s41598-020-75364-3.
10
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers.胶质母细胞瘤中的致癌功能获得与突变型p53淀粉样寡聚体有关。
iScience. 2020 Feb 21;23(2):100820. doi: 10.1016/j.isci.2020.100820. Epub 2020 Jan 8.